Episteme Prognostics has filed a notice of an exempt offering of securities to raise $3,701,047.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Episteme Prognostics is raising $3,701,047.00 in new funding. Sources indicate that as part of senior management President, Surajit Dhara played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Episteme Prognostics
Individualized epigenetics transforming the treatment of pancreatic cancer.
To learn more about Episteme Prognostics, visit http://www.epistemedx.com/
Contact:
Surajit Dhara, President
617-832-1000
https://www.linkedin.com/in/surajit-dhara-2469aa7/
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.